NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Acousia Therapeutics GmbH

Acousia Therapeutics GmbH

Private
TübingenHealthcare & Life Scienceshttps://www.acousia.com/

Last Round

VC Round

Jan 9, 2024

Total Funding Raised

$14.43M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Acousia Therapeutics GmbH is a biotechnology company that develops small molecule drugs for the treatment and prevention of sensorineural hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysensorineural hearing losssmall-molecule therapeuticsotoprotectionKv7.4 activatorhearing loss treatmentdrug discoveryclinical trialsinner-ear therapeuticshearing loss preventionototoxicityhearing biotechhearing loss drugotologytranslational research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acousia Therapeutics GmbH Comparables

Compare Acousia Therapeutics GmbH with similar companies based on industry and business-model similarity.

Acousia Therapeutics GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Audion Therapeutics
86%
AudioCure Pharma
86%
Sensorion SA
79%

Acousia Therapeutics GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 9, 2024
Series BMay 14, 2018
Series ADec 14, 2016
SeedSep 24, 2012

Acousia Therapeutics GmbH Investors

Notable investors and investment history

Acousia Therapeutics GmbH investors
InvestorRounds
Esperante VenturesVC Round
EsperanteVC Round
Boehringer Ingelheim Venture FundSeries B, Series A, Seed
Creathor VentureSeries B
KfW Development BankSeries A, Series B
LBBW Venture CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 238% MoM, reaching 1.3K.

Acousia Therapeutics GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Acousia Therapeutics GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acousia Therapeutics GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersTübingen
Employee Range4
Year Founded2012
Last FundingJan 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.